Marytery Fajardo
Neurology with Special Qualifications in Child Neurology · Miami, FLNPI 1083973572
Payments from drug & device makers
Across 809 payments — averaging $146.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neuropace, Inc.$77K
- Neurelis, Inc.$22K
- UCB, Inc.$4K
- Otter Pharmaceuticals, LLC$4K
- Jazz Pharmaceuticals Inc.$4K
- Livanova USA, Inc.$1K
- plus $5K from 27 others
What the payments were for
- Consulting fees$4,0509%
- Speaking & faculty fees$17,61340%
- Travel & lodging$3,4968%
- Food & beverage$18,41742%
- Education$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neuropace, Inc. | 134 | $77,412 |
| Neurelis, Inc. | 136 | $22,251 |
| UCB, Inc. | 125 | $4,439 |
| Otter Pharmaceuticals, LLC | 4 | $4,089 |
| Jazz Pharmaceuticals Inc. | 100 | $4,056 |
| Livanova USA, Inc. | 27 | $1,156 |
| Aquestive Therapeutics, Inc. | 44 | $682 |
| Greenwich Biosciences, Inc. | 33 | $679 |
| Sunovion Pharmaceuticals Inc. | 24 | $581 |
| Corium, LLC | 27 | $564 |
| Eisai Inc. | 22 | $421 |
| SK Life Science, Inc. | 18 | $372 |
| Supernus Pharmaceuticals, Inc. | 26 | $342 |
| Ironshore Pharmaceuticals Inc. | 22 | $318 |
| Sumitomo Pharma America, Inc. | 13 | $302 |
| Catalyst Pharmaceuticals, Inc. | 8 | $144 |
| Zogenix Inc. | 6 | $142 |
| Biogen | 6 | $136 |
| Aprecia Pharmaceuticals, LLC | 7 | $123 |
| Immedica Pharma US, Inc. | 4 | $92 |
| Biocodex, Inc. | 4 | $87 |
| Aucta Pharmaceuticals, Inc. | 3 | $69 |
| Acadia Pharmaceuticals Inc | 2 | $49 |
| Azurity Pharmaceuticals, Inc. | 2 | $48 |
| Upsher-smith Laboratories LLC | 2 | $46 |
| Neuroone Medical Technologies Corporation | 1 | $41 |
| Tris Pharma Inc | 2 | $32 |
| AbbVie | 1 | $28 |
| Novartis | 2 | $27 |
| AstraZeneca | 1 | $24 |
| Merz Pharmaceuticals, LLC | 1 | $21 |
| NS Pharma, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VALTOCO$20,483
- SYMPAZAN$4,050
- Epidiolex$1,777
- RNS Neurostimulator Kit$1,141
- RNS System$240
- Fintepla$226
- VNS - Sentiva$186
- Azstarys$144
- Briviact$125
- VNS Therapy$122
- APTIOM$121
- Fycompa$109
How this compares
$118,805 in reported general payments places this provider in the 80th percentile of 137 neurology with special qualifications in child neurology providers in Florida.
See all neurology with special qualifications in child neurology providers in Florida →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EpidiolexCannabidiol (Cbd) | 20 | $83,862 |
| XcopriCenobamate | 12 | $13,932 |
| Clobazam | 32 | $7,776 |
| Lacosamide | 12 | $1,924 |
| Levetiracetam ErLevetiracetam | 11 | $1,516 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| SK Life Science, Inc.Xcopri | $372 | $13,93212 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 137 neurology with special qualifications in child neurology providers in Florida.
Other neurology with special qualifications in child neurology in Miami
- Ian MillerMiami$1.1M
- Migvis MonduyMiami$455K
- Paula SchleiferMiami$394K
- Anuj JayakarMiami$361K
- Matt LallasMiami$339K
- Trevor ResnickMiami$313K
- Nelson SanchezMiami$255K
- Elza VasconcellosMiami$245K
- Fernando GalanMiami$103K
- Wilson Heredia NunezMiami$101K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.